Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

23.46

-0.11 (-0.47%)

Aug 14, 2025, 2:36 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	1.80M	Log In
United States Growth	-17.88%	Log In